addS

Showing posts with label ICT Procurement. Show all posts
Showing posts with label ICT Procurement. Show all posts

Monday 10 February 2014

ICT Procurement trends in Pharmaceuticals - Enterprise ICT Investment Plans: Industry Growth, Focus, Trends, Research Report, and Forecast- 2014

ICT Procurement trends in Pharmaceuticals - Enterprise ICT Investment Plans: Industry Growth, Focus, Trends, Research Report, and Forecast- 2014


Product Synopsis

This report presents the findings from a survey of 102 pharmaceutical companies regarding their approach to Information and Communications Technology (ICT) procurement. The survey investigates the way that pharmaceutical companies like to purchase technology, as well as the major IT and business objectives influencing their IT investment strategies.

Introduction and Landscape

Browse Complete report with TOC :
http://www.marketresearchreports.biz/analysis-details/ict-procurement-trends-in-pharmaceuticals-enterprise-ict-investment-plans

Why was the report written?

To highlight the criteria on which pharmaceutical companies select their ICT providers as well as the roles which have influence while making ICT purchasing decisions.

What is the current market landscape and what is changing?

Most pharmaceutical companies are keen to deploy their technologies on-site as they have to adhere to strict compliance regulations relating to data security, however the demand for hosted services is also gaining traction.

What are the key drivers behind recent market changes?

Hosting is more popular in relation to technologies such as mobility and green IT and virtualization, with the aim of achieving cost and operational efficiencies.

What makes this report unique and essential to read?

Kable Global ICT Intelligence has invested significant resources in order to interview CIOs and IT managers about their IT Procurement. Very few IT analyst houses will have interviewed 100+ ICT decision makers in the pharmaceutical industry in H2 2012.

To Download Sample Report Visit @
http://www.marketresearchreports.biz/sample/sample/183461

Key Features and Benefits

Provides insights into pharmaceutical companies' preferred buying approaches.
Comprehend the business objectives that pharmaceutical companies are looking to achieve through their IT investment strategy.
Appreciate the IT objectives that pharmaceutical companies are looking to achieve through their IT investment strategy.
Understand the factors that are influencing pharmaceutical companies' decision to select an ICT provider.
Understand which organizational roles influence ICT purchasing decisions and signing off budgets.

Key Market Issues

Pharmaceuticals companies have a higher preference for buying technologies from local resellers compared to national resellers, as they tend to be in a better position to provide timely support services and also possess vertical expertise.
The survey results indicate that pharmaceutical companies' ICT investments are focused on increasing operational efficiencies by streamlining core business processes.
The objective of cutting costs has been assigned a moderate rating of X, as pharmaceutical companies look to reduce their overheads and operational costs.
Pharmaceutical companies dealing with constrained ICT budgets are looking to deploy technology solutions that offer value for money; therefore, ICT vendors who can offer flexible pricing models will have a competitive edge over their counterparts
According to Kable's survey, 50% of Pharmaceutical companies state that they have an ICT infrastructure which is somewhat complex, with several hardware manufacturers, operating systems, databases, applications, and other elements, whilst 15% describe their ICT infrastructure as 'very complex' with multiple instances of different technology types.

To Read the Complete Report With TOC Visit: http://www.marketresearchreports.biz/analysis/183461

Key Highlights

It is evident from the survey that an average 69% of Pharmaceutical companies are deploying their ICT solutions on-site, 31% of respondents prefer the hosted model.
Business objective relating to increasing customer satisfaction also has significant influence on IT investment strategy amongst Pharmaceutical companies, with average ratings of X on a scale of 1 to 4.
Kable survey shows that respondents give the IT objective of using IT to support revenue growth the highest average rating of X on a scale of 1 to 4, indicating that pharmaceutical companies consider IT to play a pivotal role in improving their top line growth.
Pharmaceutical companies consider specific functionality expertise/depth and expertise in the pharmaceuticals industry to be the most important criteria in choosing an ICT solution provider, with average ratings of X on a scale of 1 to 4
Pharmaceutical companies rate the CIO as the most influential authority when making ICT purchasing decisions, with the highest average rating of X on a scale of 1 to 4, followed by the CFO/Finance Director (X and CEO (X).


Contact US:  
Office: United States
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States

Toll Free: 866-997-4948
Tel: +1-518-618-1030
E: sales@marketresearchreports.biz

Friday 17 January 2014

ICT Procurement trends in Pharmaceuticals - Enterprise ICT Investment Plans: Industry Growth, Focus, Trends, Research Report, and Forecast- 2014

ICT Procurement trends in Pharmaceuticals - Enterprise ICT Investment Plans: Industry Growth, Focus, Trends, Research Report, and Forecast- 2014


Product Synopsis

This report presents the findings from a survey of 102 pharmaceutical companies regarding their approach to Information and Communications Technology (ICT) procurement. The survey investigates the way that pharmaceutical companies like to purchase technology, as well as the major IT and business objectives influencing their IT investment strategies.

Introduction and Landscape

Browse Complete report with TOC :
http://www.marketresearchreports.biz/analysis-details/ict-procurement-trends-in-pharmaceuticals-enterprise-ict-investment-plans

Why was the report written?

To highlight the criteria on which pharmaceutical companies select their ICT providers as well as the roles which have influence while making ICT purchasing decisions.

What is the current market landscape and what is changing?

Most pharmaceutical companies are keen to deploy their technologies on-site as they have to adhere to strict compliance regulations relating to data security, however the demand for hosted services is also gaining traction.

What are the key drivers behind recent market changes?

Hosting is more popular in relation to technologies such as mobility and green IT and virtualization, with the aim of achieving cost and operational efficiencies.

What makes this report unique and essential to read?

Kable Global ICT Intelligence has invested significant resources in order to interview CIOs and IT managers about their IT Procurement. Very few IT analyst houses will have interviewed 100+ ICT decision makers in the pharmaceutical industry in H2 2012.

To Download Sample Report Visit @
http://www.marketresearchreports.biz/sample/sample/183461

Key Features and Benefits

Provides insights into pharmaceutical companies' preferred buying approaches.
Comprehend the business objectives that pharmaceutical companies are looking to achieve through their IT investment strategy.
Appreciate the IT objectives that pharmaceutical companies are looking to achieve through their IT investment strategy.
Understand the factors that are influencing pharmaceutical companies' decision to select an ICT provider.
Understand which organizational roles influence ICT purchasing decisions and signing off budgets.

Key Market Issues

Pharmaceuticals companies have a higher preference for buying technologies from local resellers compared to national resellers, as they tend to be in a better position to provide timely support services and also possess vertical expertise.
The survey results indicate that pharmaceutical companies' ICT investments are focused on increasing operational efficiencies by streamlining core business processes.
The objective of cutting costs has been assigned a moderate rating of X, as pharmaceutical companies look to reduce their overheads and operational costs.
Pharmaceutical companies dealing with constrained ICT budgets are looking to deploy technology solutions that offer value for money; therefore, ICT vendors who can offer flexible pricing models will have a competitive edge over their counterparts
According to Kable's survey, 50% of Pharmaceutical companies state that they have an ICT infrastructure which is somewhat complex, with several hardware manufacturers, operating systems, databases, applications, and other elements, whilst 15% describe their ICT infrastructure as 'very complex' with multiple instances of different technology types.

To Read the Complete Report With TOC Visit: http://www.marketresearchreports.biz/analysis/183461

Key Highlights

It is evident from the survey that an average 69% of Pharmaceutical companies are deploying their ICT solutions on-site, 31% of respondents prefer the hosted model.
Business objective relating to increasing customer satisfaction also has significant influence on IT investment strategy amongst Pharmaceutical companies, with average ratings of X on a scale of 1 to 4.
Kable survey shows that respondents give the IT objective of using IT to support revenue growth the highest average rating of X on a scale of 1 to 4, indicating that pharmaceutical companies consider IT to play a pivotal role in improving their top line growth.
Pharmaceutical companies consider specific functionality expertise/depth and expertise in the pharmaceuticals industry to be the most important criteria in choosing an ICT solution provider, with average ratings of X on a scale of 1 to 4
Pharmaceutical companies rate the CIO as the most influential authority when making ICT purchasing decisions, with the highest average rating of X on a scale of 1 to 4, followed by the CFO/Finance Director (X and CEO (X).


Contact US:  
Office: United States
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States

Toll Free: 866-997-4948
Tel: +1-518-618-1030
E: sales@marketresearchreports.biz

ICT Priorities in Pharmaceuticals - Enterprise ICT Investment Plans : Industry Growth, Focus, Trends, Research Report and Forecast- 2014

ICT Priorities in Pharmaceuticals - Enterprise ICT Investment Plans : Industry Growth, Focus, Trends, Research Report and Forecast- 2014


Product Synopsis

This report presents the findings from a survey of 102 pharmaceutical regarding their Information and Communications Technology (ICT) investment priorities. The survey investigates the core technologies which pharmaceutical companies are investing in, including the likes of enterprise applications, security, mobility, communications and collaboration, and Cloud Computing.

Introduction and Landscape

Why was the report written?

In order to provide deeper insights into pharmaceutical companies' ICT investment priorities and strategic objectives.

Browse Complete report with TOC : 
http://www.marketresearchreports.biz/analysis-details/ict-priorities-in-pharmaceuticals-enterprise-ict-investment-plans

What is the current market landscape and what is changing?

Kable's survey finds that apart from investing in core technologies (such as security, enterprise applications, and IT systems management), many pharmaceutical companies are looking to adopt green IT and virtualization, cloud computing, mobility, and business intelligence solutions.

What are the key drivers behind recent market changes?

Demand for such advanced technologies are increasing amongst pharmaceutical companies as these solutions will help them to reduce their costs, enhance operational efficiencies, achieve sustainability, and improve customer experience.

What makes this report unique and essential to read?

Kable Global ICT Intelligence has invested significant resources in order to interview CIOs and IT managers about their IT investment priorities. Very few IT analyst houses will have interviewed 100+ ICT decision makers in pharmaceutical industry in H2 2012.

To Download Sample Report Visit @
http://www.marketresearchreports.biz/sample/sample/183460

Key Features and Benefits

Recognize pharmaceutical companies' strategic objectives with regards to their ICT investments.
Identify pharmaceutical companies' investment priorities based on their budget allocations across core technology categories such as enterprise applications, security, mobility, communications and collaboration, and Cloud Computing, etc.
Learn about the drivers that are influencing pharmaceutical companies' investments in each technology category.
Establish how pharmaceutical companies' IT budgets are currently allocated across various segments within a technology category.
Gain insight into how pharmaceutical companies' plan to change their ICT budget allocations across various segments within a technology category.

Key Market Issues

The demand for security solutions is set to continue, with 87% of survey respondents planning investments in this area in the next two years, owing to the increasing adoption of enterprise mobility and rising data security threats in pharmaceutical companies.
Companies in the pharmaceutical sector are keen to deploy a cost effective supply chain solution in order to streamline their operations.
In order to curb the impact of competition and regulatory changes pharmaceuticals companies are looking to adopt various predictive analytics and modelling tools in order to make smarter business decisions by understanding the latest market trends and customer preferences.
Managing and monitoring the ever increasing volumes of information across a global organisation is a complex task, which is driving the adoption of various enterprise content management (ECM) solutions.
The increasing complexity of enterprise ICT infrastructure is consequently driving the demand for IT systems management to manage ICT assets effectively and keep them running efficiently, while at the same time removing any redundancies and wastage of resources.

To Read the Complete Report With TOC Visit: http://www.marketresearchreports.biz/analysis/183460
Key Highlights

With 60% of respondents planning investments in this solution through to the end of 2014, the demand for PLM solutions is set to gain momentum in the coming months.
Kable's survey finds that social sentiment analysis is set to receive increasing investments, as 53% of pharmaceutical companies are planning to invest in this technology through to the end of 2014.
The demand for tablet computing is set to increase in the near future, with 53% of pharmaceutical companies planning to invest here through to the end of 2014.
Web/video conferencing and IP-contact centres occupy the top two positions on survey respondents' priority lists. While web/video conferencing has a penetration rate of 65% among pharmaceutical companies, 63% already operate IP-contact centres.
Kable expects high levels of investment in hybrid clouds in the near future, as an increasing number of pharmaceutical companies are planning to make investments in these solutions through to the end of 2014.


Contact US:  
Office: United States
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States

Toll Free: 866-997-4948
Tel: +1-518-618-1030
E: sales@marketresearchreports.biz
Browse Complete report with TOC : http://www.marketresearchreports.biz/analysis-details/ict-priorities-in-pharmaceuticals-enterprise-ict-investment-plans